InvestorsHub Logo
Followers 34
Posts 3031
Boards Moderated 0
Alias Born 02/27/2016

Re: georgejjl post# 360182

Thursday, 05/12/2022 3:36:39 PM

Thursday, May 12, 2022 3:36:39 PM

Post# of 469878
That is a great wide ranging patent. Gives us hints to what they are seeing and shows us how fast 2-73 works.

If you have one of these symptoms, give them some 2-73 for a week, see what happens and increase dosage as needed. Nice!!

A method for treating a genetic neurodevelopmental disorder in a subject in need thereof, the method comprising: (a) evaluating the subject for the occurrence and/or severity of one or more genetic neurodevelopmental disorder symptoms selected from the group consisting of: cognitive impairment, motor learning impairment, balance impairment, muscular strength impairment, seizures, sleep dysfunction, breathing impairment, and anxiety; (b) daily administering to the subject a dosage formulation comprising a therapeutically effective amount of ANAVEX2-73 for a period of at least about 1 week, wherein the dosage formulation is selected from a liquid oral dosage formulation, a topical formulation, a transmucosal formulation, a transdermal formulation, a buccal formulation, a sublingual formulation, and a parental formulation; (c) re-evaluating the subject for the occurrence and/or severity of the symptoms evaluated in (a), and evaluating the subject for the occurrence of adverse events; and (d) optionally modifying the dosage of ANAVEX2-73 administered to the subject based on the evaluations in (c), wherein absence of improvement in at least one symptom indicates optionally increasing the dosage of ANAVEX2-73, and occurrence of an adverse event indicates decreasing the dosage of ANAVEX2-73.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News